Oral priming of mice by recombinant spores of Bacillus subtilis

Vaccine

Volumn 22, Issue 31-32, 2004, Pages 4139-4143

  Ciabattini, Annalisa ^a   Parigi, Riccardo ^a   Isticato, Rachele ^b   Oggioni, Marco R ^a   Pozzi, Gianni ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Mucosal vaccines; Prime boost; Vaccine vectors

Indexed keywords

COAT PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2B; IMMUNOLOGICAL ADJUVANT; RECOMBINANT PROTEIN; RECOMBINANT VACCINE; TETANUS TOXIN; TETANUS TOXIN FRAGMENT C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIGEN SPECIFICITY; ARTICLE; BACILLUS SUBTILIS; BACTERIAL SPORE; BACTERIAL STRAIN; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOGLOBULIN BLOOD LEVEL; INOCULATION; MOUSE; MOUSE STRAIN; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; STRAIN DIFFERENCE; TH2 CELL; WILD TYPE;

ANIMALS; ANTIBODIES, BACTERIAL; BACILLUS SUBTILIS; BACTERIAL PROTEINS; FEMALE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECOMBINANT PROTEINS; SPORES, BACTERIAL; TETANUS TOXIN;

EID: 4944234023     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.05.001     Document Type: Article

References (25)

1. A. Driks Bacillus subtilis spore coat Microbiol. Mol. Biol. Rev. 63 1 1999 1 20
2. A.O. Henriques, and C.P. Moran Jr. Structure and assembly of the bacterial endospore coat Methods 20 1 2000 95 110
3. A.J. Ozin, C.S. Samford, A.O. Henriques, and C.P. Moran Jr. SpoVID guides SafA to the spore coat in Bacillus subtilis J. Bacteriol. 183 10 2001 3041 3049
4. P.C. Turnbull Anthrax vaccines: past, present and future Vaccine 9 1991 533 539
5. N.T. Hoa, L. Baccigalupi, A. Huxham, A. Smertenko, P.H. Van, and S. Ammendola Characterization of Bacillus species used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders Appl. Environ. Microbiol. 60 12 2000 5241 5247
6. S. Senesi, F. Celandroni, A. Tavanti, and E. Ghelardi Molecular characterization and identification of Bacillus clausii strains marketed for use in oral bacteriotherapy Appl. Environ. Microbiol. 67 2 2001 834 839
7. M.R. Spinosa, F. Wallet, and M.R. Oggioni The trouble in tracing opportunistic pathogens: cholangitis due to Bacillus in a French hospital caused by a strain related to an Italian probiotic? Microb. Ecol. Health Dis. 12 2 2000 99 101
8. J. Wang, and D.Y. Fung Alkaline-fermented foods: a review with emphasis on pidan fermentation Crit. Rev. Microbiol. 22 2 1996 101 138
9. M.R. Spinosa, T. Braccini, E. Ricca, M. De Felice, L. Morelli, and G. Pozzi On the fate of ingested Bacillus spores Res. Microbiol. 151 2000 361 368
10. M.R. Oggioni, A. Ciabattini, A.M. Cuppone, and G. Pozzi Bacillus spores for vaccine delivery Vaccine 21 S2 2003 S96 101
11. R. Isticato, G. Cangiano, H.T. Tran, A. Ciabattini, D. Medaglini, and M.R. Oggioni Surface display of recombinant proteins on Bacillus subtilis spores J. Bacteriol. 183 21 2001 6294 6301
12. F. Kunst, N. Ogasawara, and I. Moszer The complete genome sequence of the gram-positive bacterium Bacillus subtilis Nature 390 6657 1997 249 256
13. D. Medaglini, A. Ciabattini, M.R. Spinosa, T. Maggi, H. Marcotte, and M.R. Oggioni Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice Vaccine 19 15/16 2001 1931 1939
14. K. Robinson, L.M. Chamberlain, K.M. Schofield, J.M. Wells, and R.W.F. Le Page Oral vaccination of mice against tetanus with recombinant Lactococcus lactis Nat. Biotechnol. 15 7 1997 653 657
15. J.E. Galen, O.G. Gomez-Duarte, and G.A. Losonsky A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens Vaccine 15 6/7 1997 700 708
16. L.H. Duc, H.A. Hong, N. Fairweather, E. Ricca, and S.M. Cutting Bacterial spores as vaccine vehicles Infect. Immun. 71 5 2003 2810 2818
17. W.L. Nicholson, and P. Setlow Sporulation, germination and outgrowth C. Harwood S. Cutting Molecular biological methods for Bacillus 1990 391 451
18. S. Ricci, D. Medaglini, and C.M. Rush Immunogenicity of the B monomer of the Escherichia coli heat-labile toxin expressed on the surface of Streptococcus gordonii Infect. Immun. 68 2 2000 760 766
19. M.J. McCluskie, R.D. Weeratna, P.J. Payette, and H.L. Davis Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA FEMS Immunol. Med. Microbiol. 32 2002 179 185
20. M. Vajdy, M. Singh, and M. Ugozzoli Enhanced mucosal and systemic immune responses to Helicobacter pylori antigens through mucosal priming followed by systemic boosting immunizations Immunology 110 2003 86 94
21. T.M. Doherty, A. Weinrich Olse, L. van Pinxteren, and P. Andersen Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosis Infect. Immun. 70 6 2002 3111 3121
22. Lauterslager TGM, W. Stok, A.T. Luuk, and A.T. Hilgers Improvement of the systemic prime/oral boost strategy for systemic and local responses Vaccine 21 2003 1391 1399
23. P. Londono-Arcila, D. Freeman, and H. Kleanthous Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen Infect. Immun. 70 9 2002 5096 5106
24. C.K. Lee, K. Soike, P. Giannasca, J. Hill, R. Weltzin, and H. Kleanthous Immunization of rhesus monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helicobacter pylori Vaccine 17 23-24 1999 3072 3082
25. Q. Kong, L. Richter, Y.F. Yang, C.J. Arntzen, H.S. Mason, and Y. Thanavala Oral immunization with hepatitis B surface antigen expressed in transgenic plants Proc. Natl. Acad. Sci. U.S.A. 98 20 2001 11539 11544